Cover [Abstract] Entity Addresses [Table] Entity Addresses, Address Type [Axis] Address Type [Domain] Business Contact [Member] Entity Addresses [Line Items] Document Type Entity Registrant Name Document Registration Statement Entity Central Index Key Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Amendment Flag Current Fiscal Year End Date Document Annual Report Document Transition Report Document Shell Company Report Entity File Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Postal Zip Code Entity Address, City or Town Entity Address, Country Contact Personnel Name Country Region City Area Code Local Phone Number Title of 12(b) Security Trading Symbol Security Exchange Name Entity Common Stock, Shares Outstanding Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Emerging Growth Company ICFR Auditor Attestation Flag Document Accounting Standard Entity Shell Company Auditor Firm ID Auditor Name Auditor Location Condensed Consolidated Balance Sheets Assets [abstract] ASSETS Non-current assets [abstract] Non-current assets Property, plant and equipment Property, plant and equipment, end of period Property, plant and equipment, beginning of period Property, plant and equipment Right-of-use assets Balance, end of period Balance, beginning of period Right-of-use assets Intangible asset Intangible Assets Intangible asset Non-current restricted cash and cash equivalents Long-term financial assets Non-current assets Total non-current assets Current assets [abstract] Current assets Current prepaid expenses Prepaid expenses Prepaid expenses including other costs Current contract assets Accrued income, ending balance Accrued income, beginning balance Accrued income The amount of current other receivables and receivables from value added taxes and withholding taxes. Current receivables classified as other and value added and withholding taxes Other current receivables Short-term financial assets Short-term financial assets Short-term financial assets due in one year or less Cash and cash equivalents Cash and cash equivalents at September 30 Cash and cash equivalents at January 1 Company's cash position Cash and cash equivalents Current assets Total current assets Assets Total assets SHAREHOLDERS' EQUITY AND LIABILITIES Shareholders' equity Issued capital Share capital Share premium Treasury shares Treasury shares Reserve of exchange differences on translation Currency translation differences Retained earnings Accumulated losses Equity Balance, end of period Balance, beginning of period Total shareholders' equity Non-current liabilities [abstract] Non-current liabilities Non-current lease liabilities Long-term lease liabilities Non-current provisions for employee benefits Net employee defined benefit liabilities Non-current liabilities Total non-current liabilities Current liabilities [abstract] Current liabilities Trade and other current payables Trade and other payables Current accrued expenses and other current liabilities Accrued expenses Total Current contract liabilities Deferred income, ending balance Deferred income, beginning balance Deferred income Deferred income Current lease liabilities Short-term lease liabilities Current liabilities Total current liabilities Liabilities Total liabilities Equity and liabilities Total shareholders' equity and liabilities Condensed Consolidated Statements of Income/(Loss) Contract revenues and other operating income Revenue Revenue from contracts with customers Contract revenue Total contract revenue Revenue Total revenue Expenses, Operating [Abstract] Operating expenses Research and development expense Research & development expenses General and administrative expense General & administrative expenses Other operating income/(expense) Operating expense Total operating expenses Profit (loss) from operating activities Operating loss Financial income Finance income associated with change in fair value of derivative financial assets Finance costs Financial expense The gain (loss) arising from the change in fair value of a convertible instrument. Gain (loss) arising from change in fair value of convertible instrument Change in fair value of conversion feature Exchange differences Finance income (cost) Net financial gains (losses) Finance result, net Income/(loss) before income tax Loss before tax Income tax expense Income tax expense Loss for the period Loss for the period Loss for the period Net loss for the period Loss per share Loss per share: Basic earnings (loss) per share Basic loss per share for the period attributable to equity holders Diluted earnings (loss) per share Diluted loss per share for the period attributable to equity holders Condensed Consolidated Statements of Comprehensive Income/(Loss) Items that will be reclassified to income or loss in subsequent periods (net of tax): Currency translation differences Components of other comprehensive income that will not be reclassified to profit or loss, net of tax [abstract] Items that will not to be reclassified to income or loss in subsequent periods (net of tax): Other comprehensive income, net of tax, gains (losses) on remeasurements of defined benefit plans Remeasurement gains on defined-benefit plans (net of tax) Remeasurement gain Comprehensive income Total comprehensive loss, net of tax Condensed Consolidated Statements of Changes in Equity Statement of changes in equity [table] Components of equity [axis] Equity [Member] Issued capital [member] Share capital Share Premium [Member] Share premium Treasury shares. Treasury shares Retained earnings [member] Accumulated losses Reserve of exchange differences on translation [member] Currency Translation Differences Statement of changes in equity [line items] Other comprehensive income Other comprehensive income/(loss) Increase (decrease) through share-based payment transactions, equity Share-based payments Share issue related cost Transaction offering costs Sale or issue of treasury shares Proceeds from sale of treasury shares in public offerings, net of underwriting fees and transaction costs Issuance of shares, net of transaction costs: The increase (decrease) in equity resulting from purchase of IPR&D assets. Increase (decrease) through purchase of in process research and development asset IPR&D asset purchase 'The increase (decrease) in equity resulting from the issuance of shares as part of an asset acquisition. Increase (decrease) through acquisition of assets, equity Asset acquisition - common shares Conversion of note agreement, net of transaction costs Conversion note agreement Held as treasury shares The increase in equity through the issue of restricted share awards. Issue of Equity, Restricted Share Awards restricted share awards Increase (decrease) through exercise of options, equity exercise of options Condensed Consolidated Statements of Cash Flows Cash flows from (used in) operating activities [abstract] Operating activities Adjustments to reconcile profit (loss) [abstract] Adjustments to reconcile net loss for the period to net cash flows: Adjustments for depreciation expense Depreciation of property, plant and equipment Adjustments for depreciation expense for right-of-use assets to reconcile profit (loss) to net cash flow from (used in) operating activities. Adjustments for depreciation expense, right-of-use assets Depreciation of right-of-use assets Adjustments for finance income (cost) Finance (income), net Adjustments for share-based payments Share-based compensation expense Adjustments for increase (decrease) in employee benefit liabilities Change in net employee defined benefit liability Adjustments for fair value losses (gains) Change in fair value of conversion feature Adjustments for interest expense Interest expense Adjustments for gain (loss) on disposals, property, plant and equipment (Gain)/loss on sale of fixed assets Changes in working capital [Abstract] Changes in working capital: Adjustments for decrease (increase) in prepaid expenses (Increase)/decrease in prepaid expenses Adjustments for decrease (increase) in contract assets Decrease in accrued income Adjustments for decrease (increase) in other operating receivables (Increase) in other current receivables Adjustments for increase (decrease) in accrued expenses to reconcile profit (loss) to net cash flow from (used in) operating activities. Adjustments for increase (decrease) in accrued expenses (Decrease) /increase in accrued expenses Adjustments for increase (decrease) in contract liabilities (Decrease) in deferred income Adjustments for increase (decrease) in trade accounts payable (Decrease) in trade and other payables Cash flows from (used in) operations Cash used in operating activities Interest received, classified as operating activities Interest received Interest paid, classified as operating activities Interest paid Finance costs paid, classified as operating activities Finance costs Cash flows from (used in) operating activities Net cash flows used in operating activities Cash flows from (used in) investing activities [abstract] Investing activities Payments (proceeds) from purchases (sales) of short-term financial assets, classified as investing activities Payments (proceeds) from purchases (sales) of short-term financial assets, classified as investing activities Short-term financial assets, net Purchase of property, plant and equipment, classified as investing activities Purchases of property, plant and equipment Proceeds from sales of property, plant and equipment, classified as investing activities Proceeds from sale of property, plant and equipment The cash outflow or inflow for deposit of rent. Cash Advances for Rent Deposit Rental deposits Cash flows from (used in) investing activities Net cash flows provided by/(used in) investing activities Cash flows from (used in) financing activities [abstract] Financing activities Payments of lease liabilities, classified as financing activities Principal payments of lease obligations Proceeds from sale or issue of treasury shares Proceeds from sale of treasury shares in public offerings, net of underwriting fees and transaction costs Payments for share issue costs Transaction costs associated with issuance of shares in relation to asset acquisition previously recorded in accrued expenses Proceeds from issue of ordinary shares Proceeds from issuance of common shares The cash inflow from the issuing of convertible debt. Proceeds from issue of convertible debt Proceeds from issuance of convertible loan Proceeds from exercise of options Proceeds from issuance of common shares - option plan, net of transaction costs Repayments of current borrowings Repayment of short-term financing obligation Payments to acquire or redeem entity's shares Payment for the issuance of treasury shares Proceeds from long-term financing obligation Cash flows from (used in) financing activities Net cash flows (used in)/provided by financing activities Increase (decrease) in cash and cash equivalents before effect of exchange rate changes Net decrease in cash and cash equivalents Effect of exchange rate changes on cash and cash equivalents Exchange gain on cash and cash equivalents Supplemental non-cash activity [Abstract] Supplemental non-cash activity Amount of property plant and equipment acquired through noncash investing activities. Purchase of property, plant and equipment, classified as noncash investing activities Capital expenditures in Trade and other payables or Accrued expenses The Issuance of shares for purchase of IPR&D asset in asset acquisition. Issuance of shares for purchase of IPR&D asset in asset acquisition The gross value of the settlement of convertible debt that is settled via shares of entity's common shares. Repayment of convertible debt, Equity Settlement, Amount Settlement of convertible notes recorded within Shareholders' equity Corporate information The entire disclosure for general information about the entity. Disclosure of general information about the entity explanatory [Text Block] Corporate information Basis of preparation and changes to accounting policies Basis of preparation and changes to the Company's accounting policies Disclosure of basis of preparation and changes to accounting policies Disclosure of basis of preparation and changes to accounting policies [Text Block] Basis of preparation and changes to the Company's accounting policies Disclosure of revenue [text block] Contract revenues and other operating income Disclosure of earnings per share [text block] Loss per share Property, plant and equipment. Disclosure of property, plant and equipment [text block] Property, plant and equipment Right-of-use assets, long-term financial assets and lease liabilities Disclosure of leases [text block] Right-of-use assets, long-term financial assets and lease liabilities Net employee defined benefit liabilities Disclosure of employee benefits [text block] Net employee defined benefit liabilities Accrued expenses Accrued expenses Disclosure of accrued expenses and other liabilities [text block] Accrued expenses Intangible assets Disclosure of intangible assets [text block] Intangible assets Prepaid expenses The disclosure of prepayments and accrued income. Disclosure of prepaid expenses and accrued income [Text Block] Prepaid expenses Cash and cash equivalents and financial assets Disclosure of restricted cash and cash equivalents [text block] Cash and cash equivalents and financial assets Treasury shares Treasury shares, Disclosure of treasury shares [text block] Treasury shares Finance income (expense) Finance result, net Disclosure of finance income (cost) [text block] Finance result, net Subsequent events Disclosure of events after reporting period [text block] Subsequent events Basis of preparation and changes to the Company' accounting policies Description of accounting policy for functional currency [text block] Functional and reporting currency The description of the entity's accounting policy for judgments that management has made in the process of applying the entity's accounting policies that have the most significant effect on amounts recognized in the financial statements along with information about the assumptions that the entity makes about the future, and other major sources of estimation uncertainty at the end of the reporting period, that have a significant risk of resulting in a material adjustment to the carrying amounts of assets and liabilities within the next year. Description of accounting policy for accounting judgments and estimates [Policy Text Block] Critical judgments and accounting estimates The description of the entity's accounting policy for fair value of financial assets and liabilities. Fair value of financial assets and liabilities [Policy Text Block] Fair value of financial assets and liabilities Basis of consolidation Description of accounting policy for foreign currency translation [text block] Foreign currency transactions The description of the entity's accounting policy for the basis for how the entity classifies assets and liabilities as current and non-current. Description of accounting policy for classification of assets and liabilities [Policy Text Block] Current vs. non-current classification Description of accounting policy for recognition of revenue [text block] Revenue recognition Description of accounting policy for research and development expense [text block] Research and development expenses General and administrative expenses The description of the entity's accounting policy for grant income. Grant income [Policy Text Block] Grant income Leases Description of accounting policy for property, plant and equipment [text block] Property, plant and equipment Description of accounting policy for intangible assets and goodwill [text block] Intangible Assets Description of accounting policy for issued capital [text block] Share capital and public offerings Description of accounting policy for treasury shares [text block] Treasury Shares Description of accounting policy for employee benefits [text block] Employee benefits Description of accounting policy for provisions [text block] Provisions Description of accounting policy for income tax [text block] Taxation Description of accounting policy for earnings per share [text block] Earnings per share Description of accounting policy for segment reporting [text block] Segment reporting The description of the entity's accounting policy for changes to accounting policies recently adopted by the entity. Disclosure Of Accounting Policy For Changes In Accounting Policies Recently Adopted [Text Block] Accounting policies, new standards, interpretations and amendments adopted by the Company Disclosure of effect of changes in foreign exchange rates [text block] Schedule of exchange rates used for translation of financial statements The disclosure of detailed information about the estimated lease term by right-of-use asset by category. Schedule of information about contract lease term by right-of-use asset categories [Table Text Block] Estimated Lease Term by Right-of-use Asset Categories The disclosure of detailed information about the useful life of property, plant and equipment. Schedule of information about property, plant and equipment useful life [Table Text Block] Estimated useful life Disclosure of revenue from contracts with customers [text block] Schedule of contract revenues Explanation of significant changes in contract assets and contract liabilities [text block] Schedule of changes in the Company's contract assets and liabilities Explanation of effect that timing of satisfaction of performance obligations and typical timing of payment have on contract assets and contract liabilities [text block] Schedule of contract revenue of performance obligations satisfied Earnings per share [text block] Schedule of earnings per share The disclosure of instruments (including contingently issuable shares) that could potentially dilute basic earnings per share in the future. Dilutive effect of convertible instruments [Text Block] Schedule of antidilutive securities Disclosure of detailed information about property, plant and equipment [text block] Schedule of movement in the net book values of property, plant and equipment Disclosure of quantitative information about right-of-use assets [text block] Schedule of the movements in the net value book value of right-of-use assets The disclosure of right-of-use assets impact on the company's statements of income/(loss) and statements of cash flows. Disclosure of right-of-use assets impact on statements [Text Block] Schedule of impact on condensed consolidated statements of income/(loss) and cash flows Tabular disclosure of information related to the contractual undiscounted cash flows. Schedule of contractual undiscounted cash flows [Table Text Block] Schedule of contractual undiscounted cash flows for lease obligations The disclosure of detailed information about trade payables and accrued liabilities. Disclosure of detailed information about trade payables and accrued liabilities [Table Text Block] Trade and other payables and accrued liabilities Tabular disclosure of information related to accrued expenses Schedule of accrued expenses [Table Text Block] Schedule of accrued expenses Disclosure of detailed information about intangible assets [text block] Schedule of net book value of intangible assets Cash and cash equivalents and short-term financial assets The number of unique proprietary platform technologies to discover, design and develop medicines and diagnostics to target misfolded proteins. Number of technology platforms Number of proprietary technology platforms Functional and reporting currency [Abstract] Closing rate, USD 1 Weighted average exchange rate, USD 1 Going Concern [Abstract] Going concern [Abstract] Disclosure of disaggregation of revenue from contracts with customers [abstract] Contract revenues Disclosure of disaggregation of revenue from contracts with customers [table] Types of contracts [axis] Types of contracts [member] The 2014 contractual research agreement associated with collaboration with Life Molecular Imaging. License and collaboration agreement of 2014, Life Molecular Imaging [Member] Disclosure of disaggregation of revenue from contracts with customers [line items] Contract revenues The increase in contract assets for the period. Contract assets, additions Accrued income, additions The decrease in contract assets for the period. Contract assets, deductions Accrued income, deductions The increase in contract liabilities for the period. Contract liabilities, addition Deferred income, additions The decrease in contract liabilities for the period. Contract liabilities, deductions Deferred income, deductions Products and services [axis] Products and services [member] This member stands for Tau PET Tracer PI-2620. Tau PET Tracer PI-2620 Amounts included in the contract liability at the beginning of the period Amounts included in the contract liability at the beginning of the period Performance obligations satisfied in previous periods Performance obligations satisfied in previous periods Amount of other current receivables from contracts with customers. Other Current Receivables From Contracts With Customers Other current receivables Revenue earned from non-repayable sum of money awarded to an entity to carry out a specific purpose as provided in grant agreements. Grant revenue [Member] Grant revenue [Member] Funding provided for certain types of expenditures in connection with research and development activities over a contractually-defined period from the Michael J. Fox Foundation. Grants, Michael J. Fox Foundation [Member] Grant from Michael J. Fox Foundation [Member] Counterparties [axis] Counterparties [member] Skane University Hospital is a university hospital in Scania, Sweden. Skane University Hospital [Member] Skane University Hospital [Member] Skane University Hospital This member represents the Michael J. Fox Foundation Michael J. Fox Foundation [Member] Michael J. Fox Foundation This member stands for Alpha Synuclein PET Imaging Diagnostic Agent. Alpha-synuclein PET imaging diagnostic agent Range [axis] Ranges [member] Minimum Bottom of Range [Member] Legal Entity [Axis] Entity [Domain] Follow-on grant funding received, total for joint arrangement Follow-on grant funding received, total for joint arrangement Follow-on grant funding received Follow-on grant funding received The number of grants received. Number of grants Number of grants received The total potential value of the collaborative agreement. Collaborative agreement, potential value Total potential collaboration agreement value Receivables from contracts with customers Eligible grant amount receivable The period over which collaborating entities are contracted to perform research, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Collaborative agreement, Joint research collaboration period Period of joint research agreement Funding provided for certain types of expenditures in connection with research and development activities over a contractually-defined period from the Target ALS Foundation. Grant from Target ALS Foundation [Member] Grant from Target ALS Foundation [Member] Maximum Maximum Basic earnings per share [abstract] Basic income/(loss) per share (EPS) [Abstract] Profit (loss), attributable to ordinary equity holders of parent entity [abstract] Numerator Profit (loss), attributable to ordinary equity holders of parent entity, used in calculating basic earnings per share Net loss attributable to equity holders of the Company Diluted income/(loss) per share (EPS) [Abstract] Weighted average ordinary shares used in calculating basic and diluted earnings per share [abstract] Denominator Weighted average number of ordinary shares used in calculating basic earnings per share Weighted-average number of shares outstanding used to compute EPS basic attributable to equity holders Weighted average number of ordinary shares used in calculating diluted earnings per share Weighted-average number of shares outstanding used to compute EPS diluted attributable to equity holders Dilutive effect of share options on number of ordinary shares Effect of dilutive securities from equity incentive plans (in shares) Antidilutive securities [Abstract] Antidilutive securities The number of dilutive share options that relate to the assumed exercise of the entity's share options. Dilutive effect of share options issued and outstanding Share options issued and outstanding The number of dilutive restricted share awards subject to future vesting that relate to the assumed exercise of the entity's incentive share options. Dilutive effect of Restricted share awards subject to future vesting Restricted share awards subject to future vesting Dilutive effect of convertible instruments on number of ordinary shares Convertible shares (in shares) The number of dilutive potential ordinary shares that relate to the assumed exercise of the entity's share options and potential ordinary shares that relate to the assumed conversion of the entity's convertible instruments. Dilutive effect of share options and convertible instruments on number of ordinary shares Total (in shares) Disclosure of detailed information about property, plant and equipment [table] Classes of property, plant and equipment [axis] Property, plant and equipment [member] Furniture IT Equipment IT Equipment This member stands for a class of property, plant and equipment representing laboratory equipment. Laboratory equipment [Member] Lab Equipment Leasehold Improvements Construction in progress [member] Assets under construction This member stands for assets under construction. Assets Under Construction Carrying amount, accumulated depreciation, amortization and impairment and gross carrying amount [axis] Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis] Carrying amount [member] Gross carrying amount [member] Gross Carrying Amount Acquisition Cost Accumulated depreciation and amortisation [member] Accumulated depreciation Accumulated Amortization Disclosure of detailed information about property, plant and equipment [line items] Reconciliation of changes in property, plant and equipment [abstract] Property, plant and equipment: Additions other than through business combinations, property, plant and equipment Additions Increase (decrease) through transfers, property, plant and equipment Transfers Depreciation, property, plant and equipment Depreciation expense Disposals, property, plant and equipment Disposals The percentage of increase in property, plant and equipment during the period. Percentage increase in property, plant and equipment Percentage of increase in equipment Disclosure of quantitative information about right-of-use assets [table] Classes of assets [axis] Assets [member] Buildings Office Equipment Disclosure of quantitative information about right-of-use assets [line items] Disclosure of quantitative information about leases for lessee [abstract] Right-of-use assets and lease liabilities: Additions and remeasurements Weighted average lessee's incremental borrowing rate applied to lease liabilities recognised at date of initial application of IFRS 16 Weighted average incremental borrowing rate Right-of-use leased assets [Abstract] Right-of-use of leased assets: Depreciation, right-of-use assets Depreciation Depreciation of right-of-use assets The amount of decrease in right-of-use assets from disposals. Dispositions of right-of-use assets Dispositions Expense relating to variable lease payments not included in measurement of lease liabilities Variable lease payments that are not included in the measurement of lease obligations Impact on statements of income/(loss) and cash flows [Abstract] Statements of income/(loss) and cash flows Interest expense on lease liabilities Interest expense on lease liabilities Expense relating to short-term leases for which recognition exemption has been used Expense for short-term leases and leases of low value The expense for leases recognized through profit and loss. Expense relating to leases Total Cash outflow for leases Total cash outflow for leases Disclosure of maturity analysis of operating lease payments [table] Maturity [axis] Aggregated time bands [member] Less than one year 1-3 years 3-5 years Disclosure of maturity analysis of operating lease payments [line items] Contractual undiscounted cash flows for lease liabilities [Abstract] Contractual undiscounted cash flows for lease liabilities: The amount of undiscounted operating lease payments due for lease liabilities. Undiscounted operating lease payments due Contractual undiscounted cash flows for lease liabilities Gross lease liabilities Contractual undiscounted cash flows for lease liabilities The number of deposits in escrow accounts. Number of deposits in escrow accounts The amount of deposits held in escrow. Escrow deposit, amount Escrow deposits Disclosure of defined benefit plans [table] Classes of ordinary shares [axis] Ordinary shares [member] Disclosure of defined benefit plans [line items] Increase (decrease) in discount rate, defined benefit plans Increase (decrease) in discount rate, defined benefit plans Increase in discount rate, defined benefit plans Actuarial assumption of discount rates Discount rate Net defined benefit liability (asset) Net assets of employee defined benefit liability Schedule disclosing information related to details of trade and other payables and accrued liabilities. Trade and other payables and accrued liabilities [Table] The 2014 contractual research agreement associated with collaboration with Janssen Pharmaceuticals. Collaboration agreement of 2014, Janssen Pharmaceuticals [Member] Janssen Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table. Trade and other payables and accrued liabilities [Line Items] The amount of current accrued research and development costs. Current accrued research and development costs Accrued research and development costs Current provisions for employee benefits Accrued payroll expenses The amount of current accrued stamp duty. Accrued stamp duty Accrued stamp duty Accruals classified as current Accrued liabilities Other current liabilities Other accrued expenses The amount of current accrued expenses. Current Accrued Expenses Accrued Expenses Payments for previous accruals Payments for previous accruals Payments for performance-related remuneration Payments for performance-related remuneration The amount of current accrued costs. Current Accrued Costs Accrued costs paid Short-term employee benefits accruals Accrual of performance-related remuneration Disclosure of detailed information about intangible assets [table] Classes of intangible assets other than goodwill [axis] Intangible assets other than goodwill [member] This member stands for an intangible asset that is a clinically-validated active vaccine candidate for the treatment of Parkinson's disease. Acquired IPR&D Asset Disclosure of detailed information about intangible assets [line items] Disclosure of intangible assets material to entity [abstract] Accumulated Amortization Discount rate applied to cash flow projections Discount rate Schedule of cash and cash equivalent balances, including foreign currencies in which the balances are denominated. Cash and cash equivalents [Table] Currency [Axis] All Currencies [Domain] Switzerland, Francs CHF [Member] Euro Member Countries, Euro EUR [Member] United States of America, Dollars USD [Member] Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table. Cash and cash equivalent [Line Items] Cash [abstract] Cash and cash equivalents [Abstract] Proceeds from disposal or maturity of available-for-sale financial assets Sale of short-term financial assets Purchase of available-for-sale financial assets Purchase of short-term financial assets Disclosure of classes of share capital [table] Disclosure of classes of share capital [line items] The number of shares that have been authorized and issued, including treasury shares held. [Refer: Treasury shares] Number of shares outstanding including treasury shares Number of shares outstanding including treasury shares Number of shares in entity held by entity or by its subsidiaries or associates Number of treasury shares outstanding Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [table] Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] Finance result, net